Ceapro Inc. Reports 2019 Second Quarter and Six-Month Financial Results and Operational Highlights August 28, 2019
Ceapro Announces Research Funding Award from the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada for Joint Projects with McMaster University August 27, 2019
Ceapro Inc. Announces Signing of a Contribution Agreement with National Research Council of Canada August 15, 2019
Ceapro Presents Positive Results from Avenanthramides Study at the 2019 American Society of Sports Medicine Meeting June 5, 2019
Ceapro Inc. Commences Patient Enrollment in First-in-Human Clinical Study Assessing Beta Glucan as a Cholesterol-Lowering Agent June 3, 2019
Ceapro Inc. Announces Positive Key Findings from Three Oral Presentations Given at European Meeting on Supercritical Fluids April 15, 2019
